Logo image of OSUR

ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

NASDAQ:OSUR - Nasdaq - US68554V1089 - Common Stock - Currency: USD

3.095  +0.09 (+2.82%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OSUR. OSUR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of OSUR is average, but there are quite some concerns on its profitability. OSUR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OSUR had negative earnings in the past year.
OSUR had a positive operating cash flow in the past year.
OSUR had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: OSUR reported negative operating cash flow in multiple years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

OSUR has a better Return On Assets (-6.98%) than 64.71% of its industry peers.
The Return On Equity of OSUR (-8.06%) is better than 67.38% of its industry peers.
Industry RankSector Rank
ROA -6.98%
ROE -8.06%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

OSUR has a worse Gross Margin (41.98%) than 65.78% of its industry peers.
In the last couple of years the Gross Margin of OSUR has declined.
The Profit Margin and Operating Margin are not available for OSUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSUR has been increased compared to 1 year ago.
Compared to 5 years ago, OSUR has more shares outstanding
Compared to 1 year ago, OSUR has an improved debt to assets ratio.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

OSUR has an Altman-Z score of 2.67. This is not the best score and indicates that OSUR is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.67, OSUR is doing good in the industry, outperforming 65.78% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, OSUR is in the better half of the industry, outperforming 71.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.67
ROIC/WACCN/A
WACC8.86%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 12.34 indicates that OSUR has no problem at all paying its short term obligations.
The Current ratio of OSUR (12.34) is better than 94.12% of its industry peers.
OSUR has a Quick Ratio of 10.94. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR has a Quick ratio of 10.94. This is amongst the best in the industry. OSUR outperforms 94.12% of its industry peers.
Industry RankSector Rank
Current Ratio 12.34
Quick Ratio 10.94
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -191.30%.
Looking at the last year, OSUR shows a very negative growth in Revenue. The Revenue has decreased by -46.94% in the last year.
The Revenue has been growing slightly by 3.75% on average over the past years.
EPS 1Y (TTM)-191.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
Revenue 1Y (TTM)-46.94%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-44.71%

3.2 Future

Based on estimates for the next years, OSUR will show a very strong growth in Earnings Per Share. The EPS will grow by 29.63% on average per year.
OSUR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.71% yearly.
EPS Next Y-192.27%
EPS Next 2Y-51.49%
EPS Next 3Y-19.5%
EPS Next 5Y29.63%
Revenue Next Year-31.27%
Revenue Next 2Y-14.32%
Revenue Next 3Y-7.32%
Revenue Next 5Y-3.71%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OSUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OSUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

OSUR's earnings are expected to decrease with -19.50% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.49%
EPS Next 3Y-19.5%

More info and screens

0

5. Dividend

5.1 Amount

OSUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (8/4/2025, 10:23:15 AM)

3.095

+0.09 (+2.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners89.56%
Inst Owner Change2.29%
Ins Owners4.71%
Ins Owner Change20.9%
Market Cap231.51M
Analysts78
Price Target6.12 (97.74%)
Short Float %5.46%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-71.32%
Min EPS beat(2)-142.2%
Max EPS beat(2)-0.43%
EPS beat(4)2
Avg EPS beat(4)-13.01%
Min EPS beat(4)-142.2%
Max EPS beat(4)67.32%
EPS beat(8)5
Avg EPS beat(8)-13.93%
EPS beat(12)8
Avg EPS beat(12)199.37%
EPS beat(16)8
Avg EPS beat(16)98.7%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)0.56%
Revenue beat(4)3
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)2.18%
Revenue beat(8)7
Avg Revenue beat(8)6.63%
Revenue beat(12)11
Avg Revenue beat(12)11.17%
Revenue beat(16)14
Avg Revenue beat(16)9.75%
PT rev (1m)33.33%
PT rev (3m)20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.59%
EPS NY rev (1m)0%
EPS NY rev (3m)-20.16%
Revenue NQ rev (1m)-0.53%
Revenue NQ rev (3m)-7.88%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)-4.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.43
P/FCF N/A
P/OCF 256.37
P/B 0.58
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY0.39%
SpS2.16
BVpS5.3
TBVpS4.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.98%
ROE -8.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.98%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.08%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.34
Quick Ratio 10.94
Altman-Z 2.67
F-Score5
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
EPS Next Y-192.27%
EPS Next 2Y-51.49%
EPS Next 3Y-19.5%
EPS Next 5Y29.63%
Revenue 1Y (TTM)-46.94%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-44.71%
Revenue Next Year-31.27%
Revenue Next 2Y-14.32%
Revenue Next 3Y-7.32%
Revenue Next 5Y-3.71%
EBIT growth 1Y-342.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-89.45%
EBIT Next 3Y44.24%
EBIT Next 5Y25.91%
FCF growth 1Y93.03%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y116.72%
OCF growth 3YN/A
OCF growth 5Y22.81%